Immunomodulating medication based on Fc fragments of human IgG

Details Immunomodulating medication based on Fc fragments of human IgG Immunomodulating medication based on Fc fragments of human IgG

1984-12-07

1988-01-12

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Lymphokine

424101, 514 21, 530387, 530388, A61K 39395, C07K 1500

Patent

active

047191074

ABSTRACT:
This medication consists of Fc fragments of human IgG, or of analogues of said fragments, and [is characterized by the fact] that it is free of intact IgG and/or Fab fragments or contains no more than 2% by weight of the latter with respect to total weight (Fc+Fab+IgG), it being understood that said analogues of Fc fragments of human IgG are all fragments or subfragments of Fc and all synthetic or semisynthetic peptides containing peptide sequences present in the Fc fragment, as well as all derivatives of these fragments, subfragments, or peptides, provided that these fragments, subfragments, peptides, or derivatives fulfill the following conditions:

REFERENCES:
patent: 4137222 (1979-01-01), Makula et al.
patent: 4465670 (1984-08-01), Sugisaki et al.
patent: 4479934 (1984-10-01), Sedlacek et al.
patent: 4544640 (1985-10-01), Soma et al.
Biochemical Journal, 73 (1959), pp. 119-126, Porter.
Journal of Immunology, 122 (1979), 89-96, Berman et al.
Journal of Experimental Medicine, 146 (1977), 241-256, Berman et al.
Journal of Experimental Medicine, 153 (1981), 1161-1172, Morgan et al.
J. Clin. Invest. 67 (1981), 867-877, Durandy et al.
Morgan et al, J. Exp. Med. 154, 1981, 778-790.
Morgan et al, J. Exp. Med. 152, 1980, 113-121.
Barandun et al, Vox Sang. 7, 157-174 (1962).
Sgouris et al, Vox Sang. 13, 71-84 (1967).
Barandun et al, Vox Sang. 28, 157-175 (1975).
Clinical Applications of Immunoglobulin, Edited by P. Lattman, Sandoz Products (1982), pp. 16-27 and 34-35, Barandun et al.
Transplantation, 34, No. 2 (1982), 90-93, Sugisaki et al.
Int. Archs. Allergy Appl. Immun. 57, 375-378 (1978), Skvaril et al.

Affiliated with

Also associated with

Rating

Immunomodulating medication based on Fc fragments of human IgG does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunomodulating medication based on Fc fragments of human IgG, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulating medication based on Fc fragments of human IgG will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-920598